Adverse event reporting
The systematic reporting of negative health effects associated with drug use. Healthcare providers and manufacturers are required to report serious adverse events to the FDA via the MedWatch system.
Frequently Asked Questions
What is Adverse event reporting?
The systematic reporting of negative health effects associated with drug use. Healthcare providers and manufacturers are required to report serious adverse events to the FDA via the MedWatch system.
Why is Adverse event reporting important in peptide research?
Understanding adverse event reporting is crucial for navigating the legal and regulatory landscape of peptide use. Regulatory knowledge helps practitioners and patients distinguish between approved therapies, compounded medications, and research chemicals.
Related Terms
Pharmacovigilance
The science and activities relating to detection, assessment, understanding, and prevention of adverse drug effects. Required for all FDA-approved drugs, including post-marketing surveillance (Phase 4).
FDA approvedA designation indicating the U.S. Food and Drug Administration has determined a drug is safe and effective for its labeled indication based on clinical trial evidence. FDA-approved peptides include semaglutide, tirzepatide, liraglutide, and PT-141.